Get the Stockscreener App
17.16
3.21%
-0.57
Embecta Corp stock is traded at $17.16, with a volume of 218.90K.
It is down -3.21% in the last 24 hours and down -13.33% over the past month.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
See More
Previous Close:
$17.73
Open:
$17.72
24h Volume:
218.90K
Relative Volume:
0.56
Market Cap:
$1.03B
Revenue:
$1.12B
Net Income/Loss:
$55.30M
P/E Ratio:
18.06
EPS:
0.95
Net Cash Flow:
$-30.30M
1W Performance:
-4.29%
1M Performance:
-13.33%
6M Performance:
+23.90%
1Y Performance:
-1.72%
1-Day Range:
$17.09
$18.07
1-Week Range:
$16.12
$18.58
52-Week Range:
$9.925
$21.48
Embecta Corp Stock (EMBC) Company Profile
Name
Embecta Corp
Sector
Industry
Phone
(862) 401-0000
Address
1209 ORANGE STREET, WILMINGTON
Compare EMBC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
17.18 | 1.03B | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
584.07 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.08 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
89.70 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.04 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
320.83 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-27-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | Wolfe Research | Peer Perform |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Sep-08-22 | Initiated | BTIG Research | Neutral |
| Aug-01-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-21-22 | Initiated | BofA Securities | Underperform |
View All
Embecta Corp Stock (EMBC) Latest News
Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.20 EPS - MarketBeat
Embecta raises FY2025 adjusted EBITDA margin guidance to 37% amid cost-cutting and debt reduction focus - MSN
Embecta Corporation Reports Q1 2025 Earnings Amid Strategic Shifts - TipRanks
Embecta earnings beat by $0.21, revenue topped estimates - Investing.com Nigeria
Embecta Corp’s Earnings Call: Growth Amid Challenges - TipRanks
Embecta earnings beat by $0.21, revenue topped estimates By Investing.com - Investing.com South Africa
Embecta Keeps Quarterly Dividend at $0.15 Per Share, Payable March 14 to Stockholders of Record on Feb. 28 - Marketscreener.com
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business - Benzinga
Embecta Corp. Announces Quarterly Cash Dividend, Payable March 14, 2025 -February 06, 2025 at 06:00 am EST - Marketscreener.com
Embecta Corp. (EMBC) Tops Q1 Earnings and Revenue Estimates - MSN
Embecta's Fiscal Q1 Adjusted Earnings Rise, Revenue Declines -February 06, 2025 at 08:43 am EST - Marketscreener.com
Embecta stock rises on Street-beating Q1 - Drug Delivery Business News
Embecta Announces Quarterly Cash Dividend -February 06, 2025 at 06:01 am EST - Marketscreener.com
Embecta (NASDAQ:EMBC) Releases FY 2025 Earnings Guidance - MarketBeat
Embecta Posts Mixed Q1 Results: EPS Beats Despite Revenue Pressure, Management Raises Key Metrics Outlook - StockTitan
Embecta Announces Quarterly Cash Dividend - Barchart
Embecta Announces Quarterly Cash Dividend -February 06, 2025 at 06:00 am EST - Marketscreener.com
(EMBC) EMBECTA CORP. Forecasts Fiscal Year 2025 Adjusted EPS Range $2.70$2.90 - Marketscreener.com
Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
embecta Announces Quarterly Cash Dividend - GlobeNewswire
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit - Benzinga
Embecta (EMBC) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
(EMBC) Proactive Strategies - Stock Traders Daily
Embecta Sets Earnings Call Date: Q1 2025 Financial Results Coming February 6 - StockTitan
embecta to Report Fiscal First Quarter 2025 Financial Results - The Bakersfield Californian
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC - Zacks Investment Research
YieldBoost Embecta From 3.3% To 33.2% Using Options - Nasdaq
Embecta Corp. (NASDAQ:EMBC) Shares Acquired by JPMorgan Chase & Co. - Defense World
Is Embecta a Medical Device Company Worth Adding to Your Portfolio? - Inkl
EMBC: Is Embecta a Medical Device Company Worth Adding to Your Portfolio? - StockNews.com
Contrasting Steakholder Foods (OTCMKTS:MTTCF) & Embecta (NASDAQ:EMBC) - Defense World
Is Embecta Back on Track After a Tough Year? - MD+DI
Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation - Mass Device
Analysts say Embecta is 'heading in the right direction' - Drug Delivery Business News
Embecta (NASDAQ:EMBC) Trading Down 4%Here's What Happened - MarketBeat
The mission: To improve the lives of half a billion people worldwide - Fast Company
Barclays PLC Buys 28,523 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Barclays PLC Has $1.38 Million Stake in Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength? - MSN
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta - Yahoo Finance
BDX: 3 Healthcare Innovators Advancing Medical Technology - StockNews.com
Principal Financial Group Inc. Sells 12,593 Shares of Embecta Corp. (NASDAQ:EMBC) - Defense World
Embecta Corp. (NASDAQ:EMBC) Stock Position Raised by Barclays PLC - MarketBeat
Geode Capital Management LLC Purchases 45,228 Shares of Embecta Corp. (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Barclays PLC - Defense World
Zacks.com featured highlights include The Gap, Embecta, Blue Bird and ZIM Integrated Shipping Services - Yahoo Finance
Embecta Corp. (NASDAQ:EMBC) Shares Purchased by Jane Street Group LLC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Shares Sold by State Street Corp - Defense World
Embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com
embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Eagle-Tribune
Embecta To Participate At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Embecta Corp Stock (EMBC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):